DE69941712D1 - Verwendung von duloxetine zur behandlung von fibromyalgie - Google Patents
Verwendung von duloxetine zur behandlung von fibromyalgieInfo
- Publication number
- DE69941712D1 DE69941712D1 DE69941712T DE69941712T DE69941712D1 DE 69941712 D1 DE69941712 D1 DE 69941712D1 DE 69941712 T DE69941712 T DE 69941712T DE 69941712 T DE69941712 T DE 69941712T DE 69941712 D1 DE69941712 D1 DE 69941712D1
- Authority
- DE
- Germany
- Prior art keywords
- duloxetines
- fibromyalgia
- treatment
- naphthalenyloxy
- propanamine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pain & Pain Management (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10037798P | 1998-09-15 | 1998-09-15 | |
PCT/US1999/020986 WO2000015223A1 (en) | 1998-09-15 | 1999-09-10 | Treatment of persistent pain |
Publications (1)
Publication Number | Publication Date |
---|---|
DE69941712D1 true DE69941712D1 (de) | 2010-01-07 |
Family
ID=22279434
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69941712T Expired - Lifetime DE69941712D1 (de) | 1998-09-15 | 1999-09-10 | Verwendung von duloxetine zur behandlung von fibromyalgie |
Country Status (15)
Country | Link |
---|---|
US (1) | US6596756B1 (de) |
EP (1) | EP1113797B1 (de) |
JP (1) | JP2002524513A (de) |
CN (1) | CN1149991C (de) |
AT (1) | ATE449603T1 (de) |
AU (1) | AU746887B2 (de) |
BR (1) | BR9913671A (de) |
CA (1) | CA2344057C (de) |
CY (1) | CY1110581T1 (de) |
DE (1) | DE69941712D1 (de) |
DK (1) | DK1113797T3 (de) |
ES (1) | ES2335067T3 (de) |
PT (1) | PT1113797E (de) |
SI (1) | SI1113797T1 (de) |
WO (1) | WO2000015223A1 (de) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2451288A1 (en) * | 2001-07-31 | 2003-02-13 | Pharmacia & Upjohn Company | Treatment of chronic pain with 3-heterocyclyl- and 3-cycloalkyl-3-aryloxypropanamines |
US6602911B2 (en) * | 2001-11-05 | 2003-08-05 | Cypress Bioscience, Inc. | Methods of treating fibromyalgia |
JP2005523334A (ja) * | 2002-04-24 | 2005-08-04 | サイプレス バイオサイエンス, インコーポレイテッド | ストレス関連障害を含む機能的身体障害の予防および処置 |
AU2003227519A1 (en) * | 2002-05-30 | 2003-12-19 | Head Explorer A/S | The use of milnacipran for the treatment of tension-type headache |
US20060167005A1 (en) * | 2002-08-29 | 2006-07-27 | David Cavalla | New therapeutic uses of (4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl) thieno [2,3-d] pyrimidine |
MXPA05004935A (es) * | 2002-11-19 | 2005-07-22 | Lilly Co Eli | Tratamiento de desordenes gastrointestinales con duloxetina. |
US20100256179A1 (en) * | 2004-03-26 | 2010-10-07 | Ucb Pharma Gmbh | Combination therapy for pain in painful diabetic neuropathy |
US20050233980A1 (en) * | 2004-04-20 | 2005-10-20 | Boehringer Ingelheim International Gmbh | CGRP-antagonist in combination with a serotonin-reuptake inhibitor for the treatment of migraine |
MX2007000793A (es) * | 2004-07-24 | 2007-03-21 | Esteve Labor Dr | Uso de compuestos activos sobre el receptor sigma para el tratamiento de alodinia mecanica. |
CN100362996C (zh) * | 2004-10-14 | 2008-01-23 | 上海医药工业研究院 | 一种度洛西汀肠溶微丸胶囊及其制备方法 |
US20060194869A1 (en) * | 2004-12-23 | 2006-08-31 | Santiago Ini | Process for preparing pharmaceutically acceptable salts of duloxetine and intermediates thereof |
EP1856087A1 (de) * | 2005-03-08 | 2007-11-21 | Teva Pharmaceutical Industries Limited | Kristallformen von (s)-(+)-n,n-dimethyl-3-(1-naphthalenyloxy)-3-(2-thienyl) propanamin-oxalat und deren herstellung |
US20070116643A1 (en) * | 2005-07-01 | 2007-05-24 | Concert Pharmaceuticals Inc. | Novel aryloxypropanamines |
EP1754476A1 (de) * | 2005-08-18 | 2007-02-21 | Schwarz Pharma Ag | Lacosamid (SPM 927) zur Behandlung von Myalgien, z.B. Fibromyalgie |
AU2006318476A1 (en) * | 2005-11-23 | 2007-05-31 | Auspex Pharmaceuticals, Inc. | Substituted aryloxypropylamines with serotoninergic and/or norepinephrinergic activity |
MX2008001079A (es) * | 2006-05-23 | 2008-03-19 | Teva Pharma | Polimorfos de hidrocloruro de duloxetina. |
SI2462990T1 (sl) * | 2006-06-15 | 2014-04-30 | Ucb Pharma Gmbh | Farmacevtski sestavek, ki obsega lakozamid in levetiracetam, s sinergističnim antikonvulzivnim učinkom |
WO2008009665A1 (en) * | 2006-07-19 | 2008-01-24 | Boehringer Ingelheim International Gmbh | Treatment of pain |
TW200846003A (en) * | 2007-03-15 | 2008-12-01 | Astellas Pharma Inc | Novel prophylactic and/or therapeutic agent for diabetic neuropathy |
US8708961B2 (en) * | 2008-01-28 | 2014-04-29 | Medsolve Technologies, Inc. | Apparatus for infusing liquid to a body |
WO2010150219A1 (en) | 2009-06-25 | 2010-12-29 | Wockhardt Research Centre | Pharmaceutical composition of duloxetine or pharmaceutically acceptable salts thereof |
AU2011224350B2 (en) * | 2010-03-09 | 2015-07-02 | Alkermes Pharma Ireland Limited | Alcohol resistant enteric pharmaceutical compositions |
TWI663984B (zh) * | 2014-10-24 | 2019-07-01 | 朗齊生物醫學股份有限公司 | 神經疾病用藥臨床新應用 |
JP2020029447A (ja) * | 2018-06-25 | 2020-02-27 | 大原薬品工業株式会社 | 腸溶性高分子及び抗付着剤を含有する顆粒 |
JP7390830B2 (ja) * | 2019-09-11 | 2023-12-04 | 日本食品化工株式会社 | 医薬活性化合物の苦味抑制剤及び苦味抑制方法 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4956388A (en) | 1986-12-22 | 1990-09-11 | Eli Lilly And Company | 3-aryloxy-3-substituted propanamines |
CA2134038C (en) | 1994-06-16 | 1997-06-03 | David Taiwai Wong | Potentiation of drug response |
US5508276A (en) | 1994-07-18 | 1996-04-16 | Eli Lilly And Company | Duloxetine enteric pellets |
ZA958725B (en) * | 1994-10-20 | 1997-04-16 | Lilly Co Eli | Treatment of disorders with duloxetine |
KR19990087671A (ko) | 1996-03-11 | 1999-12-27 | 피터 지. 스트링거 | 간질성 방광염의 치료 또는 예방 방법 |
AU725556B2 (en) * | 1996-03-25 | 2000-10-12 | Eli Lilly And Company | Method for treating pain |
US5912256A (en) * | 1996-06-20 | 1999-06-15 | Eli Lilly And Company | Compounds having effects on serotonin-related systems |
-
1999
- 1999-09-10 CN CNB998108308A patent/CN1149991C/zh not_active Expired - Lifetime
- 1999-09-10 PT PT99969026T patent/PT1113797E/pt unknown
- 1999-09-10 CA CA002344057A patent/CA2344057C/en not_active Expired - Fee Related
- 1999-09-10 DE DE69941712T patent/DE69941712D1/de not_active Expired - Lifetime
- 1999-09-10 AU AU11972/00A patent/AU746887B2/en not_active Expired
- 1999-09-10 BR BR9913671-6A patent/BR9913671A/pt not_active Application Discontinuation
- 1999-09-10 AT AT99969026T patent/ATE449603T1/de active
- 1999-09-10 SI SI9931038T patent/SI1113797T1/sl unknown
- 1999-09-10 JP JP2000569807A patent/JP2002524513A/ja active Pending
- 1999-09-10 WO PCT/US1999/020986 patent/WO2000015223A1/en active IP Right Grant
- 1999-09-10 EP EP99969026A patent/EP1113797B1/de not_active Expired - Lifetime
- 1999-09-10 DK DK99969026.6T patent/DK1113797T3/da active
- 1999-09-10 ES ES99969026T patent/ES2335067T3/es not_active Expired - Lifetime
- 1999-09-10 US US09/786,836 patent/US6596756B1/en not_active Expired - Lifetime
-
2009
- 2009-12-16 CY CY20091101314T patent/CY1110581T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
WO2000015223A1 (en) | 2000-03-23 |
DK1113797T3 (da) | 2010-02-01 |
CN1316904A (zh) | 2001-10-10 |
EP1113797A1 (de) | 2001-07-11 |
EP1113797B1 (de) | 2009-11-25 |
CA2344057C (en) | 2008-11-18 |
CA2344057A1 (en) | 2000-03-23 |
PT1113797E (pt) | 2009-12-21 |
ES2335067T3 (es) | 2010-03-18 |
CY1110581T1 (el) | 2015-04-29 |
BR9913671A (pt) | 2001-06-05 |
AU1197200A (en) | 2000-04-03 |
US6596756B1 (en) | 2003-07-22 |
SI1113797T1 (sl) | 2010-02-26 |
CN1149991C (zh) | 2004-05-19 |
ATE449603T1 (de) | 2009-12-15 |
EP1113797A4 (de) | 2006-07-05 |
AU746887B2 (en) | 2002-05-02 |
JP2002524513A (ja) | 2002-08-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69941712D1 (de) | Verwendung von duloxetine zur behandlung von fibromyalgie | |
TR200000755T2 (tr) | Karşıt olma-karşı gelme bozukluğunun tedavisi. | |
ATE279181T1 (de) | Verwendung von 5ht-6 antagonisten zur behandlung adhd | |
EA200000351A1 (ru) | Лечение кондуктивных нарушений | |
ATE365042T1 (de) | Verwendung von morpholinol zur behandlung von sexuellen funktionsstörungen | |
ATE207356T1 (de) | Verwendung von tiagabin zur behandlung von schlafstörungen | |
EA199700208A1 (ru) | Тиенил-, фурил-, пирролил- и дифенилсульфонамиды и их производные, модулирующие активность эндотелина | |
DE60114580D1 (de) | Verwendung von cyanochinolinen zur behandlung oder inhibierung von dickdarmpolypen | |
DE69609868D1 (de) | Neue steroidester zur behandlung von hauterkrankungen | |
ATE225176T1 (de) | Verwendung von serotonin-antagonisten (5ht3) zur behandlung von fibromyalgie | |
JP2002524513A5 (de) | ||
DE122009000036I2 (de) | Verwendung von Dapoxetin, ein selektiver Serotonin Aufnahme Inhibitor mit schnellem Wirkungseintritt, zur Behandlung von sexueller Dysfunktion | |
DE60014928D1 (de) | Retinoide zur behandlung von emphysem | |
DE69920205D1 (de) | Verwendung von metall-proteinase-inhibitoren, um das wachstum der haare oder körperhaare zu induzieren und/oder zu stimulieren und/oder den haarausfall zu verlangsamen | |
DE69825440D1 (de) | VERWENDUNG VON TAUROLIDINE ZUR Herstellung eines Arzneimittels zur BEHANDLUNG VON LEUKÄMIEN | |
DE69638281D1 (de) | Anti-Interleukin-9 Antikörper oder Anti-Interleukin-9 Rezeptor Antikörper zur Behandlung von bronchialem Hyperreaktionsvermögen | |
DE59202663D1 (de) | Verwendung eines UV-Strahlers zur Behandlung von Oberflächen. | |
EP0756869A3 (de) | Verwendung von Duloxetin oder von N-Alkyl-3-phenyl-(2-alkylthiophenoxy)-Propylaminen zur Behandlung von Aufmerksamkeitsstörungen und Hyperaktivität | |
EA200200948A1 (ru) | Лечение псориаза | |
DE69737029D1 (de) | Biomembran zur substitution, rekonstruktion, induktion der angiogenese, neubildung oder regeneration von menschlichen oder tierischen organen oder gewebe | |
DE69721747D1 (de) | Methode zur behandlung oder verhütung von interstitieller blasenentzundung | |
DE60220825D1 (de) | Verwendung von norepinephrinwiederaufnahmehemmern zur behandlung von ticks | |
DE69904849D1 (de) | 3-tetrahydropyridin-4-yl-indole zur behandlung von psychotischen störungen | |
DE69736180D1 (de) | Behandlung von manischen erkrankungen | |
DE60033569D1 (de) | Neue verwendung von prodigiosin zur behandlung von diabetes mellitus |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8328 | Change in the person/name/address of the agent |
Representative=s name: DR. SCHOEN & PARTNER, 80336 MUENCHEN |